This page includes the latest FDA filings for Aclaris Therapeutics Inc. Currently, you will find the latest 100 filings for Premarket Notifications, Premarket Applications, De Novo Applications, and GUDID registrations.
| USA | NASDAQ | ACRS | DUNS 032365882 |
Device Company | Device | Date |
|---|---|---|
| Aclaris Therapeutics, Inc., DPT Laboratories, Ltd. | Prescription Medication | 2019-12-06 |
| Aclaris Therapeutics, Inc., DPT Laboratories, Ltd. | Prescription Medication | 2019-10-25 |
| Aclaris Therapeutics, Inc., DPT Laboratories, Ltd. | Prescription Medication | 2019-06-25 |
| Aclaris Therapeutics, Inc., James Alexander Corp. | Prescription Medication | 2019-03-28 |
| Aclaris Therapeutics, Inc. | Eskata | 2017-12-14 |
| Aclaris Therapeutics, Inc. | Eskata | 2017-12-14 |
| Aclaris Therapeutics, Inc. | Rhofade | 2017-01-18 |
| SEC | 0001557746 | Aclaris Therapeutics, Inc. of DELAWARE |